Natrecor Is Associated With Increased Risk Of Acute Renal Failure And Death
September 20th, 2007 Posted by: Dr. Cox
Questions About Safety Of Natrecor Continue, With No Apparent Resolution Any Time Soon
(Posted by Tom Lamb at DrugInjuryWatch.com)
As reported previously, in June 2007 Scios, Inc. announced it had started enrolling patients in a 7,000-patient trial designed to “assess the long-term clinical outcomes and benefit/risk profile of Natrecor (nesiritide) in patients with acutely decompensated heart failure (ADHF)”.